GHP Investment Advisors Inc. boosted its stake in Maximus, Inc. (NYSE:MMS – Free Report) by 4.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 32,151 shares of the health services provider’s stock after purchasing an additional 1,443 shares during the period. GHP Investment Advisors Inc. owned approximately 0.05% of Maximus worth $2,995,000 at the end of the most recent reporting period.
Other hedge funds also recently added to or reduced their stakes in the company. Assenagon Asset Management S.A. boosted its position in shares of Maximus by 151.6% in the second quarter. Assenagon Asset Management S.A. now owns 233,134 shares of the health services provider’s stock worth $19,980,000 after buying an additional 140,481 shares during the period. Healthcare of Ontario Pension Plan Trust Fund grew its position in Maximus by 942.9% in the second quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 323,300 shares of the health services provider’s stock valued at $27,707,000 after acquiring an additional 292,300 shares in the last quarter. Tidal Investments LLC grew its position in Maximus by 238.9% in the first quarter. Tidal Investments LLC now owns 12,763 shares of the health services provider’s stock valued at $1,071,000 after acquiring an additional 8,997 shares in the last quarter. SG Americas Securities LLC raised its stake in shares of Maximus by 609.6% during the second quarter. SG Americas Securities LLC now owns 14,278 shares of the health services provider’s stock valued at $1,224,000 after purchasing an additional 12,266 shares during the period. Finally, Entropy Technologies LP acquired a new position in shares of Maximus during the first quarter worth $491,000. 97.21% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling at Maximus
In other news, insider Michelle F. Link sold 1,363 shares of Maximus stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of $92.56, for a total value of $126,159.28. Following the completion of the transaction, the insider now owns 6,567 shares in the company, valued at approximately $607,841.52. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.40% of the stock is currently owned by insiders.
Maximus Price Performance
Maximus (NYSE:MMS – Get Free Report) last issued its quarterly earnings results on Wednesday, August 7th. The health services provider reported $1.74 EPS for the quarter, beating analysts’ consensus estimates of $1.47 by $0.27. The firm had revenue of $1.31 billion during the quarter, compared to the consensus estimate of $1.29 billion. Maximus had a return on equity of 20.91% and a net margin of 5.59%. Maximus’s revenue for the quarter was up 10.6% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.78 earnings per share. Equities research analysts expect that Maximus, Inc. will post 6.12 EPS for the current fiscal year.
Maximus Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Saturday, November 30th. Investors of record on Friday, November 15th will be issued a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 1.38%. The ex-dividend date of this dividend is Friday, November 15th. Maximus’s dividend payout ratio is currently 25.16%.
Maximus Company Profile
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Recommended Stories
- Five stocks we like better than Maximus
- How to Find Undervalued Stocks
- Real Estate Sector Outperforms: 3 Stocks to Gain Exposure
- Trading Stocks: RSI and Why it’s Useful
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- How to Invest in Biotech Stocks
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS – Free Report).
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.